Z-2123-2012 Class II Terminated
FDA device recall Z-2123-2012 was initiated by Integra LifeSciences Corp. on Feb 9, 2012 and is designated Class II. Reason for recall: Incorrect technique applied may cause potential rupture of the tibialis anterior tendon during surgery. The recall status is terminated (terminated Feb 19, 2013). Affected quantity: 2,437 units.
Recall details
- Product Type
- Devices
- Report Date
- Aug 8, 2012
- Initiation Date
- Feb 9, 2012
- Termination Date
- Feb 19, 2013
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 2,437 units
Product description
Reason for recall
Distribution pattern
Worldwide Distribution - USA including AK, AL, AR, AZ, CA, CO, CT, DC, FL, GA, IA, ID, IN, KS, KY, LA, MA, MD, MI, MN, MO, NC, NE, NH, NM, NJ, NY, NV, OH, OK, OR, PA, RI, SC, TN, TX, UT, VA, WA & WI and internationally to Belgium; Danemark; France; Germany; Isra¿l; Italy; Lebanon; Luxemburg; Netherlands; Norway; Portugal; Saudi Arabia; Spain; Switzerland; Turkey & United Kingdom.
Code information
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-2123-2012
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026